多沙唑嗪降脂作用研究进展

ADVANCES IN RESEARCH ON THE ANTIHYPERLIPEMIA ACTION OF DOXAZOSIN

多沙唑嗪是一种新型的选择性肾上腺α_1-受体阻滞剂,具有明确的降压和降脂作用。本文对其降脂作用机理进行了讨论。

Doxazosin,a new selective α_1-adrenorecepter blocking agent,has a definite antihypertension and antihypertipemia activities.The models of its antihyperlipemia mechanisms are reviewed by the authors.